Foundry Partners, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2021$486,000
-40.7%
5,002
-31.5%
0.02%
-50.0%
Q4 2020$819,000
+20.4%
7,301
-0.5%
0.03%
-3.0%
Q3 2020$680,000
-42.6%
7,335
-51.7%
0.03%
-43.1%
Q2 2020$1,185,000
+28.5%
15,188
-3.7%
0.06%
+11.5%
Q1 2020$922,000
-27.0%
15,7660.0%0.05%
+8.3%
Q4 2019$1,263,000
+1.2%
15,766
-7.2%
0.05%
-5.9%
Q3 2019$1,248,000
-18.2%
16,992
+5.0%
0.05%
-15.0%
Q2 2019$1,526,000
+17.5%
16,180
-0.3%
0.06%
+15.4%
Q1 2019$1,299,000
-33.9%
16,227
-45.5%
0.05%
+30.0%
Q4 2018$1,965,000
+69.0%
29,781
+99.8%
0.04%
-9.1%
Q3 2018$1,163,000
+22.7%
14,903
-0.2%
0.04%
+12.8%
Q2 2018$948,000
-35.0%
14,926
-6.1%
0.04%
-37.1%
Q1 2018$1,458,000
+21.3%
15,902
-0.3%
0.06%
+24.0%
Q4 2017$1,202,000
-52.8%
15,942
-56.4%
0.05%
-51.0%
Q3 2017$2,549,000
+37.1%
36,580
-0.3%
0.10%
+34.2%
Q2 2017$1,859,000
+23.9%
36,687
-2.2%
0.08%
+20.6%
Q1 2017$1,501,000
+42.3%
37,531
-0.2%
0.06%
+37.0%
Q4 2016$1,055,00037,6160.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders